RXMD - Progressive Care, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
23,124
20,936
20,111
18,319
13,643
Cost of Revenue
18,189
16,248
14,645
13,259
10,165
Gross Profit
4,935
4,688
5,466
5,059
3,478
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
6,778
6,188
5,247
4,756
3,965
Total Operating Expenses
6,778
6,188
5,247
4,756
3,965
Operating Income or Loss
-1,843
-1,500
219
303
-488
Interest Expense
847
303
104
66
1,852
Total Other Income/Expenses Net
402
175
26
-26
1,132
Income Before Tax
-2,288
-1,628
141
211
-1,207
Income Tax Expense
3
2
2
2
12
Income from Continuing Operations
-2,291
-1,629
140
209
-1,219
Net Income
-2,291
-1,630
49
209
-1,219
Net Income available to common shareholders
-2,291
-1,630
49
209
-1,219
Reported EPS
Basic
-
-0.00
0.00
0.00
-0.01
Diluted
-
-0.00
0.00
0.00
-0.01
Weighted average shares outstanding
Basic
-
418,130
346,326
343,546
155,614
Diluted
-
418,130
346,326
343,546
155,614
EBITDA
-
-1,166
335
310
669